These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 31499940

  • 1. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines.
    Goel S, Mishra P.
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109881. PubMed ID: 31499940
    [Abstract] [Full Text] [Related]

  • 2. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
    Shahein SA, Aboul-Enein AM, Higazy IM, Abou-Elella F, Lojkowski W, Ahmed ER, Mousa SA, AbouAitah K.
    Int J Nanomedicine; 2019 Nov; 14():5503-5526. PubMed ID: 31410001
    [Abstract] [Full Text] [Related]

  • 3. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
    Tambe P, Kumar P, Paknikar KM, Gajbhiye V.
    Int J Nanomedicine; 2018 Nov; 13():7669-7680. PubMed ID: 30538451
    [Abstract] [Full Text] [Related]

  • 4. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
    Mehanna MM, Sarieddine R, Alwattar JK, Chouaib R, Gali-Muhtasib H.
    Int J Nanomedicine; 2020 Nov; 15():9557-9570. PubMed ID: 33293807
    [Abstract] [Full Text] [Related]

  • 5. Targeting of Thymoquinone-loaded mesoporous silica nanoparticles to different brain areas: In vivo study.
    Fahmy HM, Fathy MM, Abd-Elbadia RA, Elshemey WM.
    Life Sci; 2019 Apr 01; 222():94-102. PubMed ID: 30826496
    [Abstract] [Full Text] [Related]

  • 6. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity.
    Al-Hayali M, Garces A, Stocks M, Collins H, Bradshaw TD.
    Molecules; 2021 Aug 25; 26(17):. PubMed ID: 34500570
    [Abstract] [Full Text] [Related]

  • 7. Novel lipid-coated mesoporous silica nanoparticles loaded with thymoquinone formulation to increase its bioavailability in the brain and organs of Wistar rats.
    Fahmy HM, Ahmed MM, Mohamed AS, Shams-Eldin E, Abd El-Daim TM, El-Feky AS, Mustafa AB, Abd Alrahman MW, Mohammed FF, Fathy MM.
    BMC Pharmacol Toxicol; 2022 Sep 26; 23(1):71. PubMed ID: 36163187
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells.
    Ahmad R, Kaus NHM, Hamid S.
    Adv Exp Med Biol; 2020 Sep 26; 1292():65-82. PubMed ID: 30560443
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P, Tambe P, Paknikar KM, Gajbhiye V.
    Colloids Surf B Biointerfaces; 2017 Aug 01; 156():203-212. PubMed ID: 28531877
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
    Ali OM, Bekhit AA, Khattab SN, Helmy MW, Abdel-Ghany YS, Teleb M, Elzoghby AO.
    Colloids Surf B Biointerfaces; 2020 Apr 01; 188():110824. PubMed ID: 32023511
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum.
    Shahabi S, Döscher S, Bollhorst T, Treccani L, Maas M, Dringen R, Rezwan K.
    ACS Appl Mater Interfaces; 2015 Dec 09; 7(48):26880-91. PubMed ID: 26562468
    [Abstract] [Full Text] [Related]

  • 16. Innovative approach against cancer: Thymoquinone-loaded PHEMA-based magnetic nanoparticles and their effects on MCF-7 breast cancer.
    Yıldırım M, Acet Ö, Önal Acet B, Karakoç V, Odabaşı M.
    Biochem Biophys Res Commun; 2024 Nov 19; 734():150464. PubMed ID: 39083970
    [Abstract] [Full Text] [Related]

  • 17. ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood-brain barrier.
    Shen Y, Cao B, Snyder NR, Woeppel KM, Eles JR, Cui XT.
    J Nanobiotechnology; 2018 Feb 13; 16(1):13. PubMed ID: 29433522
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of double mesoporous core-shell silica spheres with tunable core porosity and their drug release and cancer cell apoptosis properties.
    El-Toni AM, Khan A, Ibrahim MA, Labis JP, badr G, Al-Hoshan M, Yin S, Sato T.
    J Colloid Interface Sci; 2012 Jul 15; 378(1):83-92. PubMed ID: 22551476
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells.
    Bertucci A, Prasetyanto EA, Septiadi D, Manicardi A, Brognara E, Gambari R, Corradini R, De Cola L.
    Small; 2015 Nov 11; 11(42):5687-95. PubMed ID: 26395266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.